Session date:
01/16/2019 - 12:10pm to 1:00pm
Omar F. Abou Ezzeddine, M.D., C.M., M.S.
Assistant Professor of Cardiology
Angela Dispenzieri, M.D.
Professor of Laboratory Medicine and Pathology
Professor of Hematology
Martha Grogan, M.D.
Assistant Professor of Cardiology
Locations:
- Geffen Auditorium (Live)
- Broadcast to SMH Alfred M-459 and Baldwin 4-316/Baldwin 4-516
- Mayo Clinic Health System in Waycross (Video Conference)
Lunch available outside Geffen Auditorium and SMH Alfred M-459 on a first-come, first-serve basis.
Learning Objectives:
- Recognize the increasing awareness of age-related amyloidosis
- Identify when to consider the diagnosis of age-related amyloidosis
- Differentiate between age-related amyloidosis and other types of amyloidosis
- Demonstrate existing and emerging therapies for these treatable diseases
Financial Disclosures:
- Dr. About Ezzeddine: Grant/Research Support - Pfizer, Inc.
- Dr. Dispenzieri: Grant/Research Support - Takeda, Pfizer, Prothena, Celgene, Janssen, and Alnylam
- Dr. Grogran: Grant/Research Support - Pfizer, Inc., Alnylam, Eidos, Prothena
Off Label/Investigational Uses:
- None
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.
Presenter:
Omar F. Abou Ezzeddine, M.D., C.M., M.S.
Co-presenter:
Angela Dispenzieri, M.D.
Additional presenter:
Martha Grogan, M.D.
Where did the idea for the course originate?:
Minnesota
Where did the idea for the course originate?:
Minnesota

Facebook
X
LinkedIn
Forward